Emergências e Terapia Intensiva
Comissão Lancet | Especialistas alertam para o aumento da supermedicalização da morte e fazem um chamado para repensar, radicalmente, o modo como a sociedade cuida das pessoas em fase final de vida.
4 Fev, 2022 | 15:16hComunicado de imprensa: THE LANCET: Experts warn of the increasing overmedicalization of death, call for radical rethink of how society cares for dying people
Página principal: Lancet Commission on the Value of Death (necessário cadastro gratuito para todos os artigos)
Report of the Lancet Commission on the Value of Death: bringing death back into life
The precariousness of balancing life and death
Ros Taylor: seeing palliative care as relational
Conteúdo relacionado: What would it take to die well? A systematic review of systematic reviews on the conditions for a good death – The Lancet Health Longevity
Comentário no Twitter (fio – clique para saber mais)
Increasing overmedicalisation at the end of life is denying people & their families a good death.
Towards a compassionate community model: The Lancet #ValueofDeath Commission calls for a radical rethink of care for the dying & attitudes to death. https://t.co/DpJiu1tOcV pic.twitter.com/FU9MgCO1J6
— The Lancet (@TheLancet) January 31, 2022
Atualização do consenso de especialistas sobre a classificação SCAI SHOCK do choque cardiogênico.
4 Fev, 2022 | 15:14hComunicado de imprensa: SCAI releases updated expert consensus to SCAI SHOCK classification – Society for Cardiovascular Angiography and Interventions
Comentários:
SCAI SHOCK: Update Refines Cardiogenic Shock Classification – TCTMD
SCAI Releases Updated Expert Consensus to SCAI SHOCK Classification – American College of Cardiology
Comentários no Twitter
.@SCAI SHOCK stage is an indication of shock severity & comprises one component of mortality risk prediction in pts w/ CS, along w/ etiology/phenotype & other risk modifiers; a 3-axis model of risk stratification in CS has been proposed. Learn more: https://t.co/tnh2JFhHzN #JACC pic.twitter.com/yK2ye9wcd0
— JACC Journals (@JACCJournals) January 31, 2022
SCAI SHOCK Stage Classification Expert Consensus Update released today in the inaugural issue of @MyJSCAI and also in @JACCJournals. Thank you to endorsing societies @ACCinTouch @american_heart @ACEPNow @escardio @ACVCPresident @ISHLT @SCCM @STS_CTsurgery https://t.co/GHrYn5I5WO pic.twitter.com/Y0mKC0zONu
— SCAI Now (@SCAI) January 31, 2022
Estudo observacional | Envolvimento farmacêutico no cuidado de pacientes críticos pode reduzir a utilização de recursos, os eventos adversos medicamentosos e os custos médicos.
4 Fev, 2022 | 15:11h
Comentário do autor no Twitter (fio – clique para saber mais)
PHARM-CRIT Study
👩🔬 215 ICU PharmDs at 85 centers
💊55,926 accepted interventions on 27,681 patients over 3,148 shifts
💵$23,404,089 cost avoidance; monetary benefit-to-cost ratio for ICU pharmacists $3.3:1 – $9.6:1@SCCM_CPP @SCCM #TwitteRx #PharmICU https://t.co/Hv4jPwU6eb— Megan Rech, PharmD, MS (@MeganARech) December 16, 2021
Consenso | Nefrotoxinas e lesão renal aguda.
4 Fev, 2022 | 15:01hM-A | Vasopressina e glicocorticoides na parada cardíaca em pacientes internados.
4 Fev, 2022 | 14:56hConteúdo relacionado: RCT: Vasopressin + Methylprednisolone increase the likelihood of return of spontaneous circulation compared to placebo in patients with in-hospital cardiac arrest.
Comentário no Twitter
Systemic review and meta analysis post VAM-IHCA.
▶️ Moderate certainty for benefit with steroids and vasopressin on ROSC
▶️ Less certainty for longer term outcomes @mathiasholmb@LarsWAndersen1 @AsgerGranfeldthttps://t.co/K3jZ1gBs1h— Critical Care Reviews (@CritCareReviews) January 4, 2022
Revisão | Tratamento multidisciplinar da lesão traqueobrônquica.
4 Fev, 2022 | 14:27hMultidisciplinary management of tracheobronchial injury – European Respiratory Review
FDA interrompe o uso de anticorpos monoclonais que não funcionam contra a Ômicron.
31 Jan, 2022 | 08:56hFDA halts use of antibody drugs that don’t work vs. omicron – Associated Press
Conteúdo relacionado: Lab study shows new antiviral pills maintain efficacy against Omicron, but antibody drugs are substantially less effective.
Diretrizes ELSO para circuitos de oxigenação extracorpórea para pacientes adultos e pediátricos.
31 Jan, 2022 | 08:47hELSO Guidelines for Adult and Pediatric Extracorporeal Membrane Oxygenation Circuits – ASAIO Journal
Conteúdo relacionado: ELSO Guidelines for anticoagulation in adult and pediatric patients using extracorporeal membrane oxygenation (ECMO).
Comentário no Twitter
The new ELSO guidelines, describing #ECMO circuits for all
patient populations, adult and pediatric, are now available, open access on @asaiojournal These consensus guidelines describe safe practice based on extensive experience.
Download full text #FOAMcchttps://t.co/Miu9sbY2gs pic.twitter.com/HU6zCwX031— ELSO (@ELSOOrg) January 28, 2022
Resumo de diretriz | Tratamento dos 10 eventos adversos imunológicos mais comuns em pacientes em imunoterapia.
31 Jan, 2022 | 08:39hArtigo original: ASCO Guideline Update: Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy.
Conteúdos relacionados:
Clinical practice guideline on immune checkpoint inhibitor-related adverse events.
NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities (várias fontes sobre o tema)
Estudo randomizado | Imunoglobulina hiperimune não melhorou os desfechos de pacientes internados com COVID-19.
28 Jan, 2022 | 17:24hComentários: